Arcturus Therapeutics Holdings Profit Margin

The latest profit margin for ARCT is -350.86% as of June 2026. That compares with -41.08% in the prior-year period — down 754.1% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Arcturus Therapeutics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARCT's profit margin moved from -41.08% to -350.86% — a 754.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arcturus Therapeutics Holdings's valuation or profitability profile.

Against Healthcare companies, ARCT currently prints -350.86% for profit margin, while the sector average sits near 13.76%. That is roughly 2649.8% below the sector mean. Large gaps often invite a closer look at Arcturus Therapeutics Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Arcturus Therapeutics Holdings converts resources into returns. At -350.86%, ARCT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -41.08% in the prior-year period — down 754.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARCT's profit margin (-350.86%), review year-over-year change from -41.08%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.